-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
ERYtech Pharma
Identification
Nome strumento
ERYTECH PHARMA
Ticker
ERYPA
Codice ISIN
FR0011471135
Mercato
Euronext
Borsa
Paris
Products family
Stocks
Comparto
Compartment C
ICB
Pharmaceuticals
Activity description
ERYtech Pharma est spécialisé dans le développement et la fabrication de produits thérapeutiques destinés au traitement des pathologies graves, des indications orphelines ou des sous-populations de patients notamment dans les domaines de l'hématologie, du cancer et des maladies métaboliques. Par ailleurs, le groupe propose des prestations de recherche et de développement pour compte de tiers.
Source : Cofisem
Indirizzo web
http://www.erytech.com
Operation
Data IPO
Mar 07/05/2013
Tipologia IPO
Introduction par offre au public
Categoria
IPO
Calendario
30 APR 2013 Listing
07 MAY 2013 Trading
Intervallo di prezzo
Prix d'émission: 10,50 - 12,70 EUR
Capitale raccolto
17,68